Canada markets closed

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.2300+0.0100 (+4.55%)
At close: 03:58PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 38.36M
Enterprise Value 39.36M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)42.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.01

Trading Information

Stock Price History

Beta (5Y Monthly) -0.04
52-Week Change 3-72.62%
S&P500 52-Week Change 3-8.83%
52 Week High 30.9500
52 Week Low 30.1700
50-Day Moving Average 30.2060
200-Day Moving Average 30.3487

Share Statistics

Avg Vol (3 month) 326.16k
Avg Vol (10 day) 328.32k
Shares Outstanding 5174.34M
Implied Shares Outstanding 6N/A
Float 8139.12M
% Held by Insiders 128.02%
% Held by Institutions 116.55%
Shares Short (Jun 14, 2022) 425.21k
Short Ratio (Jun 14, 2022) 40.96
Short % of Float (Jun 14, 2022) 40.02%
Short % of Shares Outstanding (Jun 14, 2022) 40.01%
Shares Short (prior month May 12, 2022) 462.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2021
Most Recent Quarter (mrq)Apr 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-167.53%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.16M
Net Income Avi to Common (ttm)-7.95M
Diluted EPS (ttm)-0.0560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.88M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.88M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.69
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-6.46M
Levered Free Cash Flow (ttm)-4.05M